Curis | CRIS - Ordinary Share Capital


Curis reported $2M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.38M 172K Mar/2026
Amgen USD 541M 1000K Jun/2026
AstraZeneca USD 1.55B 44K Jun/2026
Bayer EUR 982.42M 0 Jun/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
CSL USD 482.13M 93.87M Dec/2025
Curis USD 2M 10.93M Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Exelixis USD 248.88M 4.82M Jun/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
Merck USD 2.47B 4.93M Mar/2026
Novartis USD 1.9B 7.38M Jun/2026
Pfizer USD 5.7B 0 Jun/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Sanofi EUR 1.21B 8.25M Mar/2026
Takeda JPY 1.58B 460K Jun/2026
TG Therapeutics USD 153.08M 2.23M Jun/2026
Verastem USD 87.84M 10.1M Mar/2026